The University of Iowa is reporting that a new eye lens developed to replace native ones in cataract patients is to be trialed for its novel ability of reducing the halo effect common in current implantable lenses. We’ve written about similar technology, but can’t confirm the same team is behind it. Though the lenses are interesting in (Read more...)
BioLight expands relationship with Ora to develop TeaRx multi-parameter diagnostic test for DES
BioLight Life Sciences Investments, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced that it has expanded its relationship with Ora, Inc., a world-leading independent, fu…
Actavis now Allergan, creates one of the world’s top 10 pharma companies
Actavis has adopted Allergan plc as its new global name and will trade under a new stock symbol, AGN, which was announced at the opening bell at the New York Stock Exchange.The name change was approved by Actavis shareholders on June 5, according to th…
Imprimis reports $1.6 million in revenue in first quarter
Imprimis Pharmaceuticals reported total revenue of $1.6 million in the first quarter of 2015 compared with $2,000 in the first quarter of the previous year, according to a press release. Net loss was reported at $3.1 million, or $0.33 per common share,…
Ocugen to Present at BIO International Convention
AURORA, Colo.–(BUSINESS WIRE)–Ocugen, Inc. today announced leadership updates and that company Chairman and CEO Dr. Shankar Musunuri will present at BIO International Convention this week in Philadelphia.
Trained Imagers Catch Most Diabetic Retinopathy at Point of Care
Trained nonphysician imagers are able to evaluate patients for diabetic retinopathy in primary care, using a novel technology, ultrawide field imaging, reducing the work load of central reading centers. Medscape Medical News